Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 11030
MIM: 601558
HGNC: 19097
Ensembl: ENSG00000157110
Variants:
dbSNP: 11030
ClinVar: 11030
TCGA: ENSG00000157110
COSMIC: RBPMS
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37890031 | 2024 | RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing. | 2 |
| 38195842 | 2024 | SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation. | 0 |
| 37890031 | 2024 | RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing. | 2 |
| 38195842 | 2024 | SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation. | 0 |
| 36989351 | 2023 | mRNA translational specialization by RBPMS presets the competence for cardiac commitment in hESCs. | 10 |
| 37548402 | 2023 | Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators. | 1 |
| 36989351 | 2023 | mRNA translational specialization by RBPMS presets the competence for cardiac commitment in hESCs. | 10 |
| 37548402 | 2023 | Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators. | 1 |
| 35008958 | 2022 | Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells. | 3 |
| 36423381 | 2022 | Loss of RBPMS in ovarian cancer compromises the efficacy of EGFR inhibitor gefitinib through activating HER2/AKT/mTOR/P70S6K signaling. | 0 |
| 36499073 | 2022 | Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells. | 4 |
| 35008958 | 2022 | Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells. | 3 |
| 36423381 | 2022 | Loss of RBPMS in ovarian cancer compromises the efficacy of EGFR inhibitor gefitinib through activating HER2/AKT/mTOR/P70S6K signaling. | 0 |
| 36499073 | 2022 | Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells. | 4 |
| 29423656 | 2018 | RNA-binding protein Rbpms is represented in human retinas by isoforms A and C and its transcriptional regulation involves Sp1-binding site. | 5 |
Citation
Dessen P
RBPMS (RNA binding protein, mRNA processing factor)
Atlas Genet Cytogenet Oncol Haematol. 2010-01-01
Online version: http://atlasgeneticsoncology.org/gene/51248/rbpms
